These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24646155)

  • 1. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
    Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
    Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
    Benndorf RA; Schwedhelm E; Gnann A; Taheri R; Kom G; Didié M; Steenpass A; Ergün S; Böger RH
    Circ Res; 2008 Oct; 103(9):1037-46. PubMed ID: 18802021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseases.
    Greco A; Minghetti L
    Curr Neurovasc Res; 2004 Oct; 1(4):341-54. PubMed ID: 16181083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular biology of the isoprostanes.
    Cracowski JL; Devillier P; Durand T; Stanke-Labesque F; Bessard G
    J Vasc Res; 2001; 38(2):93-103. PubMed ID: 11316945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells.
    Yura T; Fukunaga M; Khan R; Nassar GN; Badr KF; Montero A
    Kidney Int; 1999 Aug; 56(2):471-8. PubMed ID: 10432385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
    Cracowski JL; Durand T; Bessard G
    Trends Pharmacol Sci; 2002 Aug; 23(8):360-6. PubMed ID: 12377577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.
    Roberts LJ; Morrow JD
    Cell Mol Life Sci; 2002 May; 59(5):808-20. PubMed ID: 12088281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprostanes--markers of ischaemia reperfusion injury.
    Sakamoto H; Corcoran TB; Laffey JG; Shorten GD
    Eur J Anaesthesiol; 2002 Aug; 19(8):550-9. PubMed ID: 12200943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus.
    Chen JX; O'Mara PW; Poole SD; Brown N; Ehinger NJ; Slaughter JC; Paria BC; Aschner JL; Reese J
    Pediatr Res; 2012 Aug; 72(2):122-8. PubMed ID: 22565502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors regulating isoprostane formation in vivo.
    Basu S; Helmersson J
    Antioxid Redox Signal; 2005; 7(1-2):221-35. PubMed ID: 15650410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The F2-isoprostane 8-iso-PGF
    Braun H; Hauke M; Eckenstaler R; Petermann M; Ripperger A; Kühn N; Schwedhelm E; Ludwig-Kraus B; Kraus FB; Dubourg V; Zernecke A; Schreier B; Gekle M; Benndorf RA
    Free Radic Biol Med; 2022 May; 185():36-45. PubMed ID: 35470061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.
    Morrow JD; Roberts LJ
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 2):S25-30. PubMed ID: 12471085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biochemistry of the isoprostane, neuroprostane, and isofuran Pathways of lipid peroxidation.
    Roberts LJ; Fessel JP; Davies SS
    Brain Pathol; 2005 Apr; 15(2):143-8. PubMed ID: 15912887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet therapy: targeting the TxA2 pathway.
    Fontana P; Zufferey A; Daali Y; Reny JL
    J Cardiovasc Transl Res; 2014 Feb; 7(1):29-38. PubMed ID: 24353037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isoprostanes: unique products of arachidonic acid oxidation-a review.
    Fam SS; Morrow JD
    Curr Med Chem; 2003 Sep; 10(17):1723-40. PubMed ID: 12871112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress.
    Basu S
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):219-25. PubMed ID: 20363116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress, isoprostanes and hepatic fibrosis.
    Comporti M; Arezzini B; Signorini C; Vecchio D; Gardi C
    Histol Histopathol; 2009 Jul; 24(7):893-900. PubMed ID: 19475535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation, isoprostanes and vascular damage.
    Minuz P; Fava C; Lechi A
    Pharmacol Rep; 2006; 58 Suppl():57-68. PubMed ID: 17332673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in vivo.
    Yin H
    Biofactors; 2008; 34(2):109-24. PubMed ID: 19706977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.